Generex Biotechnology Corporation Share Price OTC Bulletin Board
Equities
US3714851033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
01-19 | Motion for Asset Sale Approved for Generex Biotechnology Corporation | CI |
2023 | Motion for Asset Sale Filed by Generex Biotechnology Corporation | CI |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 20/11/17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 31/12/16 |
Terry Thompson
COO | Chief Operating Officer | 65 | 24/06/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 29/02/04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 31/12/04 |
Craig Eagle
BRD | Director/Board Member | 57 | 20/11/17 |
1st Jan change | Capi. | |
---|---|---|
+17.49% | 122B | |
+19.92% | 116B | |
+21.63% | 27.03B | |
-20.99% | 20.36B | |
-16.75% | 16.43B | |
-18.37% | 15.91B | |
-44.35% | 15.6B | |
+63.28% | 14.94B | |
+1.08% | 13.59B |